+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UK Defibrillators Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: United Kingdom
  • Orion Market Research Private Limited
  • ID: 4969039
The UK has one of the finest healthcare systems in the EU region, which enable it to provide quality healthcare to the individual citizens. According to British Heart Foundation, more than one- fourth of the fatalities in the UK occur due to CVD, and it is responsible for around 1.6 million fatalities each year. The critical factors that lead to CVD, CHD, stroke and other heart diseases include harmful stress, depression, excessive consumption of alcohol, excessive smoking, hypertension, diabetes, obesity and poor diet, which includes cholesterol.

CHD is the leading cause of mortality in the UK and nearly one in six men and one in ten women loses their life due to CHD. According to WHO, CHD is responsible for around 0.7 million deaths every year in the UK. Rise in aging population is increasing the prevalence rate of CHD, CVD, stroke and other heart diseases. Every year, 0.23 million elderly patients aged 75 or above lose their life due to CHD. There are around 2.3 million people living with CHD and around 1.89 million CVD patients live across the region. According to British Heart Foundation, 0.17 million heart attacks occur every year in the UK. Of the total, 0.11 million men and 0.06 million women lose their life annually in the UK due to heart attack each year. Stroke causes more than 0.04 million fatalities each year and around 1.3 million people suffer from stroke each year.

Further, the presence of key players such as Aero Healthcare, which is one of the key suppliers in the UK's healthcare Industry. The company is a majorUK Importer and Distributor for HeartSine Defibrillators. Aero Healthcare has serviced the industry for over 10 years and well placed to handle the AED needs through its extensive distributor network throughout the UK. Aero's ISO 13485 accreditation provides their end-users with assurance as they are dedicated only to highest standards.

Research Methodology

The market study of the UK Defibrillators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. UK Defibrillators Market Research and Analysis by Type
2. UK Defibrillators Market Research and Analysis by End-users

The Report Covers
  • Comprehensive research methodology of the UK Defibrillators market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK Defibrillators market.
  • Insights about market determinants which are stimulating the UK Defibrillators market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. UK Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. UK Defibrillators Market by End-Users
5.2.1. Hospitals
5.2.2. Ambulatory Services and Others
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. AeroHealthcareAU Pty Ltd.
6.3. Biotronik SE & Co. KG
6.4. Cintas Corp.
6.5. Defibtech, LLC
6.6. Fukuda Denshi Co. Ltd.
6.7. General Electric Co.
6.8. Koninklijke Philips N.V.
6.9. LivaNova PLC
6.10. Medtronic PLC
6.11. Mindray Medical International Co. Ltd.
6.12. Nihon Kohden Corp.
6.13. Stryker Corp.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • AeroHealthcareAU Pty Ltd.
  • Biotronik SE & Co. KG
  • Cintas Corp.
  • Defibtech, LLC
  • Fukuda Denshi Co. Ltd.
  • General Electric Co.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • Mindray Medical International Co. Ltd.
  • Nihon Kohden Corp.
  • Stryker Corp.